Echocardiography study in volunteers taking mianserin and amitriptyline

Reference

• Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 1978; 16: 273–3011. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 1978; 16: 273–301
   PubMed Web of Science ®Google Scholar
• Burgess C. D., Turner P., Wadsworth J. Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. Br. J. Clin. Pharmacol. 1978; 5: 21S–28S, Suppl. 12. Burgess C. D., Turner P., Wadsworth J. Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. Br. J. Clin. Pharmacol. 1978; 5: 21S–28S, Suppl. 1
   Google Scholar
• Coppen A., Gupta R., Montgomery S., Ghose K., Bailey J., Burns B., De Ridder J. J. Mianserin hydrochloride: a novel antidepressant. Br. J. Psychiatry 1976; 129: 342–3453. Coppen A., Gupta R., Montgomery S., Ghose K., Bailey J., Burns B., De Ridder J. J. Mianserin hydrochloride: a novel antidepressant. Br. J. Psychiatry 1976; 129: 342–345
   PubMed Web of Science ®Google Scholar
• De Maria A. N., Neumann F. A., Schubart P. J., Lee G., Mason D. T. Systematic correlation for cardiac chamber size and ventricular performance determined with echocardiography and alterations in heart rate in normal persons. Am. J. Cardiol. 1979; 43: 1–94. De Maria A. N., Neumann F. A., Schubart P. J., Lee G., Mason D. T. Systematic correlation for cardiac chamber size and ventricular performance determined with echocardiography and alterations in heart rate in normal persons. Am. J. Cardiol. 1979; 43: 1–9
   PubMed Web of Science ®Google Scholar
• Jaskari M. O., Ahlfors U. G., Ginman L., Lydecken K., Tienari P. Three double-blind comparative trials of mianserin (Org GB94) and amitriptyline in the treatment of depressive illness. Pharmakopsychiatr. Neuropsychopharmakol. 1977; 10: 101–1035. Jaskari M. O., Ahlfors U. G., Ginman L., Lydecken K., Tienari P. Three double-blind comparative trials of mianserin (Org GB94) and amitriptyline in the treatment of depressive illness. Pharmakopsychiatr. Neuropsychopharmakol. 1977; 10: 101–103
   PubMedGoogle Scholar
• Jefferson J. W. A review of cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom. Med. 1975; 37: 160–1796. Jefferson J. W. A review of cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom. Med. 1975; 37: 160–179
   PubMed Web of Science ®Google Scholar
• Karliner J. S., O'Rowke R. A. Usefulness and limitations of assessment of internal shortening velocity by ultrasound in man. Chest 1975; 68: 361–3647. Karliner J. S., O'Rowke R. A. Usefulness and limitations of assessment of internal shortening velocity by ultrasound in man. Chest 1975; 68: 361–364
   PubMed Web of Science ®Google Scholar
• Kopera H. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br. J. Clin. Pharmacol. 1978; 5: 29S–34S, Suppl. 18. Kopera H. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br. J. Clin. Pharmacol. 1978; 5: 29S–34S, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Peet M., Tienari P., Jaskari M. O. A comparison of the cardiac effects of mianserin and amitriptyline in man. Pharmakopsychiatr. Neuropsychopharmakol 1977; 10: 3099. Peet M., Tienari P., Jaskari M. O. A comparison of the cardiac effects of mianserin and amitriptyline in man. Pharmakopsychiatr. Neuropsychopharmakol 1977; 10: 309
   PubMedGoogle Scholar
• Rasmussen E. B., Kristjansen P. ECG changes during amitriptyline treatment. Am. J. Psychiatry 1963; 119: 781–78210. Rasmussen E. B., Kristjansen P. ECG changes during amitriptyline treatment. Am. J. Psychiatry 1963; 119: 781–782
   PubMed Web of Science ®Google Scholar
• Sunshine I. “Methodology for Analytical Toxicology”. CRC Press, Bocha-Roton, Florida 197511. Sunshine I. “Methodology for Analytical Toxicology”. CRC Press, Bocha-Roton, Florida 1975
   Google Scholar
• Thorstrand C. Cardiovascular effects of poisoning with tricyclic antidepressants. Acta Med. Scand. 1974; 195: 505–51112. Thorstrand C. Cardiovascular effects of poisoning with tricyclic antidepressants. Acta Med. Scand. 1974; 195: 505–511
   PubMed Web of Science ®Google Scholar
• Thorstrand C. Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG. Acta Med. Scand. 1976; 199: 337–34413. Thorstrand C. Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG. Acta Med. Scand. 1976; 199: 337–344
   PubMed Web of Science ®Google Scholar
• Vogel H. P., Bente D., Feder J., Helmchen H., Müller-Oerlinghausen B., Bohacek N., Mihovilovic M., BrÄndli A., Fleischhauer J., Walcher W. Mianserin versus amitriptyline. A double-blind trial evaluated by the AMP system. Int. Pharmacopsychiatry 1976; 11: 25–3114. Vogel H. P., Bente D., Feder J., Helmchen H., Müller-Oerlinghausen B., Bohacek N., Mihovilovic M., BrÄndli A., Fleischhauer J., Walcher W. Mianserin versus amitriptyline. A double-blind trial evaluated by the AMP system. Int. Pharmacopsychiatry 1976; 11: 25–31
   PubMedGoogle Scholar
• Vohra J., Burrows G. D., Sloman J. G. Assessment of cardiovascular side-effects of therapeutic doses of tricyclic antidepressant drugs. Aust. N.Z. J. Med. 1975; 5: 7–1115. Vohra J., Burrows G. D., Sloman J. G. Assessment of cardiovascular side-effects of therapeutic doses of tricyclic antidepressant drugs. Aust. N.Z. J. Med. 1975; 5: 7–11
   PubMedGoogle Scholar
• Wester H.-A., Schill W., Louton T., Schmidt P., Siegers C.-P. Computer assisted analysis of echocardiograms. Z. Biomediz. Techn. 1979, In Press16. Wester H.-A., Schill W., Louton T., Schmidt P., Siegers C.-P. Computer assisted analysis of echocardiograms. Z. Biomediz. Techn. 1979, In Press
   Google Scholar
• Glassman A. H., Bigger J. T., Giardina E. V., Kantor S. J., Perel J. M., Davies M. Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet 1979; 1: 46817. Glassman A. H., Bigger J. T., Giardina E. V., Kantor S. J., Perel J. M., Davies M. Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet 1979; 1: 468
   PubMed Web of Science ®Google Scholar
• Hayes J. R., Born G. F., Rosenbaum A. H. Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants. Mayo Clin. Proc 1977; 52: 50918. Hayes J. R., Born G. F., Rosenbaum A. H. Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants. Mayo Clin. Proc 1977; 52: 509
   PubMed Web of Science ®Google Scholar
• Kopera H. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br. J. Clin. Pharmacol. 1978; 5: 29S, Suppl. 119. Kopera H. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br. J. Clin. Pharmacol. 1978; 5: 29S, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Kopera H., Fluch N., Harpf H., Klein W. W., Stulemeijer S. Cardiovascular effects of mianserin, a comparative study with amitriptyline and placebo in healthy subjects. Int. J. Clin. Pharmacol. 1980, In Press20. Kopera H., Fluch N., Harpf H., Klein W. W., Stulemeijer S. Cardiovascular effects of mianserin, a comparative study with amitriptyline and placebo in healthy subjects. Int. J. Clin. Pharmacol. 1980, In Press
   Google Scholar